Nadroparin 3800 IU | Libya (BAYADERCARE)
Trusted anticoagulant solution for effective clot management.
Nadroparin 3800 IU Prefilled Syringe | BAYADERCARE Libya
Trusted Solution for Critical CareBalanced anticoagulation is essential in managing patients who require both preventive and therapeutic support for thromboembolic conditions. Low molecular weight heparins (LMWH) are widely used across Libyan healthcare settings due to their predictable anticoagulant response, safety profile, and clinical effectiveness.
NADROBARA® (Nadroparin Injection) is developed by RAWIA INTERNATIONAL HEALTHCARE (RIHCA) in collaboration with leading pharmaceutical manufacturing partners and is available across Libya through BAYADERCARE. The 3800 IU strength supports both thromboprophylaxis and therapeutic anticoagulation, serving hospitals, clinics, and healthcare professionals in Tripoli, Benghazi, Misrata, and across Libya — To Share • To Care • To Inspire.
NADROBARA® 3800 IU (Nadroparin Calcium) is a low molecular weight heparin (LMWH) designed for both preventive and therapeutic anticoagulation. It works by inhibiting factor Xa activity, helping to reduce clot formation and maintain stable blood circulation.
This strength is widely used in clinical practice for patients requiring effective anticoagulant therapy, including those undergoing surgical procedures or receiving treatment for venous thromboembolism (VTE), under medical supervision.
Specifications Table
| Parameter | Details |
| Brand Name | NADROBARA® |
| Generic Name | Nadroparin Calcium |
| Arabic Name | نادروبارا نادروبارين كالسيوم |
| Category | Anticoagulants |
| Therapeutic Area | Low Molecular Weight Heparin (LMWH) |
| Dosage Form | Prefilled Syringe |
| Strength | 3800 IU |
| Volume | 0.4 ml |
| Route / Type | Subcutaneous (Anti-Xa) |
| Developed By | RIHCA |
| Marketed By | RAWIACARE |
| Availability | Libya via BAYADERCARE |
| Official Libya Proxy | BAYADERCARE |
| Official Global Platform | RAWIACARE / RAWIACARE GLOBAL |
| Corporate Philosophy | TO SHARE • TO CARE • TO INSPIRE |
Applications / Uses
| Prevention and treatment of Deep Vein Thrombosis (DVT) |
| Management of Venous Thromboembolism (VTE) |
| Post-surgical anticoagulation |
| Anticoagulant therapy in moderate-risk patients |
| Hospital and clinical treatment protocols |
Nadrobara Nadroparin Calcium 2850 IU Prefilled Syringe
Nadrobara Nadroparin Calcium 2850 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.
Nadrobara Nadroparin Calcium 3800 IU Prefilled Syringe
Nadrobara Nadroparin Calcium 3800 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.
Nadrobara Nadroparin Calcium 5700 IU Prefilled Syringe
Nadrobara Nadroparin Calcium 5700 IU Anti-Xa prefilled syringe for anticoagulant support and thrombosis management in hospitals and clinics in Libya.
FAQ
Is NADROBARA 3800 IU available in Libya?
Yes, it is available through BAYADERCARE across Libya.
What is NADROBARA 3800 IU used for?
| It is used for both prevention and treatment of thromboembolic conditions such as DVT and VTE. |
How does Nadroparin work?
It inhibits factor Xa activity, helping to reduce clot formation and maintain proper blood circulation.
Where is this strength commonly used?
| Hospitals, clinics, surgical units, and specialized healthcare centers across Libya. |
What strengths are available?
| 2850 IU |
| 3800 IU |
| 5700 IU |